Loading...
XNAS
SILK
Market cap1.12bUSD
Sep 16, Last price  
27.49USD
Name

Silk Road Medical Inc

Chart & Performance

D1W1MN
P/E
—
P/S
6.31
EPS
—
Div Yield, %
—
Shrs. gr., 5y
6.21%
Rev. gr., 5y
38.66%
Revenues
177m
+27.77%
14,258,00034,557,00063,354,00075,227,000101,475,000138,638,000177,134,000
Net income
-56m
L-3.92%
-19,356,000-37,629,000-56,073,000-50,385,000-50,387,000-58,016,000-55,743,000
CFO
-32m
L-1.74%
-25,252,000-21,695,000-29,610,000-42,068,000-38,935,000-32,581,000-32,014,000
Earnings
Aug 05, 2025

Profile

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
URL
https://silkroadmed.com/
IPO date
Apr 04, 2019
Employees
414
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
177,134
27.77%
138,638
36.62%
Cost of revenue
236,405
190,642
Unusual Expense (Income)
NOPBT
(59,271)
(52,004)
NOPBT Margin
Operating Taxes
43
3,006
Tax Rate
NOPAT
(59,314)
(55,010)
Net income
(55,743)
-3.92%
(58,016)
15.14%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,887
114,788
BB yield
Debt
Debt current
1,703
1,844
Long-term debt
82,930
76,440
Deferred revenue
Other long-term liabilities
8,249
6,726
Net debt
(106,297)
(135,545)
Cash flow
Cash from operating activities
(32,014)
(32,581)
CAPEX
(1,507)
(5,005)
Cash from investing activities
(7,176)
(162,068)
Cash from financing activities
3,887
139,699
FCF
(76,746)
(64,351)
Balance
Cash
181,474
213,674
Long term investments
9,456
155
Excess cash
182,073
206,897
Stockholders' equity
(399,344)
(343,840)
Invested Capital
636,073
590,881
ROIC
ROCE
EV
Common stock shares outstanding
38,804
35,776
Price
Market cap
EV
EBITDA
(55,479)
(48,836)
EV/EBITDA
Interest
6,871
5,098
Interest/NOPBT